Trial NCT03221634

View at ClinicalTrials.gov 
Org. Study IDs: 3475-668
Secondary IDs: 2017-001001-32

Last trial update was posted on 2019-03-25

MeSH Interventions

Daratumumab Pembrolizumab

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Business Reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID